A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies

Clinical Nephrology

Volumn 59, Issue 6, 2003, Pages 463-470

  Don, B R ^a   Chin, A I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcific uremic arteriolopathy; Calciphylaxis; Therapy

Indexed keywords

ATORVASTATIN; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; GLIPIZIDE; INSULIN; METOLAZONE; OXYGEN; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; QUININE SULFATE; RECOMBINANT ERYTHROPOIETIN; ROSIGLITAZONE; SEVELAMER;

ADULT; ARTERY CALCIFICATION; ARTICLE; CASE REPORT; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; GANGRENE; HEMODIALYSIS; HUMAN; HYPERBARIC OXYGEN; HYPERPHOSPHATEMIA; INFECTION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROIDECTOMY; PATIENT ATTITUDE; RISK FACTOR; RISK MANAGEMENT; SEPSIS; SKIN CALCIFICATION; SKIN ULCER; TREATMENT OUTCOME;

EID: 0038039183     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP59463     Document Type: Article

References (37)

1. Adrogue HJ, Frazier MR, Zeluff B, Suki WN 1981 Systemic calciphylaxis revisited. Am J Nephrol 1: 177-183
2. Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM 2001 Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37: 1267-1276
3. Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL 1998 A case control study of proximal calciphylaxis. Am J Kidney Dis 32: 376-383
4. Bleyer AJ, Garrett B, Kant KS, Lynch D, Rahman N, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E 2002 An open-label cross-over study of the new phosphate binder RenaGel in the management of hyperphosphatemia in ESRD patients. Am J Kidney Dis 33: 694-701
5. Budisavljevic MN, Cheek D, Ploth DW 1996 Calciphylaxis in chronic renal failure. J Am Soc Nephrol 7: 978-982
6. Campistol JM, Almirall J, Martin E, Torras A, Revert L 1989 Calcium-carbonate-induced calciphylaxis. Nephron 51: 549-550
7. Chan YL, Mahony JF, Turner JJ, Posen S 1983 The vascular lesions associated with skin necrosis in renal disease. Br J Dermatol 109: 85-95
8. Chertow GM, Burke SK, Lazarus JM, Stenzel KH, Wombolt D, Goldberg D, Bonventre JV, Slatopolsky E 1997 Poly[allylamine hydrochloride] (RenaGel): a non-calcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis 29: 66-71
9. Chertow GM, Burke SK, Raggi P 2002 Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252
10. Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP 1998 Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32: 384-391
11. Duh QY, Lim RC, Clark OH 1991 Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy. Arch Surg 126: 1213-1218
12. Fine A, Zacharias J 2002 Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 61: 2210-2217
13. Fischer AH, Morris DJ 1995 Pathogenesis of calciphylaxis: study of three cases with literature review. Hum Pathol 26: 1055-1064
14. Fox R, Banowsky LH, Cruz ABJ 1983 Post-renal transplant calciphylaxis: successful treatment with parathyroidectomy. J Urol 129: 362-363
15. Gipstein RM, Coburn JW, Adams DA, Lee DB, Parsa KP, Sellers A, Suki WN, Massry SG 1976 Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med 136: 1273-1280
16. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483
17. Kang AS, McCarthy JT, Rowland C, Farley DR, van Heerden JA 2000 Is calciphylaxis best treated surgically or medically? Surgery 128: 967-971
18. Khafif RA, DeLima C, Silverberg A, Frankel R 1990 Calciphylaxis and systemic calcinosis. Collective review. Arch Intern Med 150: 956-959
19. Kleinpeter MA 2000 Spectrum of complications related to secondary hyperparathyroidism in a peritoneal dialysis patient. Adv Perit Dial 16: 286-290
20. Levin A, Mehta RL, Goldstein MB 1993 Mathematical formulation to help identify the patient at risk of ischemic tissue necrosis - a potentially lethal complication of chronic renal failure. Am J Nephrol 13: 448-453
21. Llach F 1998 Calcific uremic arteriolopathy (calciphylaxis): an evolving entity? Am J Kidney Dis 32: 514-518
22. Llach F 2001 The evolving pattern of calciphylaxis: therapeutic considerations. Nephrol Dial Transplant 16: 448-451
23. Martin KJ, Gellens M, Hamm LL, Abboud H, Lindberg J 1998 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol 9: 1427-1432
24. Mawad HW, Sawaya BP, Sarin R, Malluche HH 1999 Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol 52: 160-166
25. Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen CO 2001 Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60: 324-332
26. Mehta RL, Scott G, Sloand JA, Francis CW 1990 Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. Am J Med 88: 252-257
27. Podymow T, Wherrett C, Burns KD 2001 Hyperbaric oxygen in the treatment of calciphylaxis: a case series. Nephrol Dial Transplant 16: 2176-2180
28. Roe SM, Graham LD, Brock WB, Barker DE 1994 Calciphylaxis: early recognition and management. Am Surg 60: 81-86
29. Ruggian JC, Maesaka JK, Fishbane S 1996 Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis 28: 409-414
30. Russell R, Brookshire MA, Zekonis M, Moe SM 2002 Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care. Clin Nephrol 58: 238-243
31. Selye H 1962 Calciphylaxis. University of Chicago Press, Chicago
32. Smiley CM, Hanlon SU, Michel DM 2000 Calciphylaxis in moderate renal insufficiency: changing disease concepts. Am J Nephrol 20: 324-328
33. Takahashi F, Finch JL, Dusso DM, Brown AJ, Slatopolsky E 1997 A new analog of 1,25-(OH)2D3,19-Nor-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Am J Kidney Dis 30: 105-112
34. Tibbles PM, Edelsberg JS 1996 Hyperbaric-oxygen therapy. N Engl J Med 334: 1642-1648
35. Vassa N, Twardowski ZJ, Campbell J 1994 Hyperbaric oxygen therapy in calciphylaxis-induced skin necrosis in a peritoneal dialysis patient. Am J Kidney Dis 23: 878-881
36. Wilmer WA, Voroshilova O, Singh I, Middendorf DF, Cosio FG 2001 Transcutaneous oxygen tension in patients with calciphylaxis. Am J Kidney Dis 37: 797-806
37. Zacharias JV, Fontaine B, Fine A 1999 Calcium use increases risk of calciphylaxis: a case-control study. Perit Dial Int 19: 248-252